A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)

D Price, S Musgrave, E Wilson, E Sims, L Shepstone, A Blyth, J Murdoch, M Mugford, E Juniper, J Ayres, S Wolfe, D Freeman, A Lipp, R Gilbert, I Harvey

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)1-132
Number of pages132
JournalHealth Technology Assessment
Volume15
Issue number21
DOIs
Publication statusPublished - May 2011

Cite this

Price, D., Musgrave, S., Wilson, E., Sims, E., Shepstone, L., Blyth, A., Murdoch, J., Mugford, M., Juniper, E., Ayres, J., Wolfe, S., Freeman, D., Lipp, A., Gilbert, R., & Harvey, I. (2011). A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Health Technology Assessment, 15(21), 1-132. https://doi.org/10.3310/hta15210